PH25365A - Rhase l inhibitor as a marker for virus infections - Google Patents

Rhase l inhibitor as a marker for virus infections

Info

Publication number
PH25365A
PH25365A PH36551A PH36551A PH25365A PH 25365 A PH25365 A PH 25365A PH 36551 A PH36551 A PH 36551A PH 36551 A PH36551 A PH 36551A PH 25365 A PH25365 A PH 25365A
Authority
PH
Philippines
Prior art keywords
rhase
marker
inhibitor
virus infections
infections
Prior art date
Application number
PH36551A
Other languages
English (en)
Inventor
William A Carter
Original Assignee
Hem Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Research filed Critical Hem Research
Publication of PH25365A publication Critical patent/PH25365A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701Specific hybridization probes
    • C12Q1/702Specific hybridization probes for retroviruses
    • C12Q1/703Viruses associated with AIDS

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • AIDS & HIV (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PH36551A 1987-12-23 1988-02-24 Rhase l inhibitor as a marker for virus infections PH25365A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13697887A 1987-12-23 1987-12-23

Publications (1)

Publication Number Publication Date
PH25365A true PH25365A (en) 1991-05-13

Family

ID=22475294

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36551A PH25365A (en) 1987-12-23 1988-02-24 Rhase l inhibitor as a marker for virus infections

Country Status (17)

Country Link
EP (1) EP0325018A3 (fr)
JP (1) JP2690493B2 (fr)
KR (1) KR890010562A (fr)
CN (1) CN1043569A (fr)
AU (2) AU1256488A (fr)
CA (1) CA1337277C (fr)
DK (1) DK112988A (fr)
FI (1) FI880960L (fr)
HU (1) HU205460B (fr)
IL (1) IL85577A0 (fr)
NO (1) NO880935L (fr)
OA (1) OA08815A (fr)
PH (1) PH25365A (fr)
PT (1) PT86880B (fr)
RU (1) RU1836101C (fr)
SU (1) SU1687035A3 (fr)
ZA (1) ZA881470B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5278042A (en) * 1989-02-06 1994-01-11 The United States Of America As Represented By The Department Of Health & Human Services Method for detecting inhibitors of tat protein
FR2725214A1 (fr) * 1994-09-30 1996-04-05 Inst Nat Sante Rech Med Nouveaux composes utilisables pour la preparation d'agents anti-infectieux
US5985565A (en) * 1996-10-09 1999-11-16 Temple University-Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
CN101818145A (zh) 1998-03-20 2010-09-01 联邦科学和工业研究组织 控制基因表达
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
CA2361201A1 (fr) 1999-01-28 2000-08-03 Medical College Of Georgia Research Institute, Inc. Composition et methode destinees a l'attenuation in vivo et in vitro de l'expression genique utilisant de l'arn double brin
US6207366B1 (en) 1999-04-14 2001-03-27 Temple University- Of The Commonwealth System Of Higher Education Chronic fatigue syndrome diagnosis
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
CA2369944A1 (fr) 2001-01-31 2002-07-31 Nucleonics Inc. Utilisation de l'inhibition genetique post-transcriptionnelle pour identifier les sequences d'acides nucleiques qui modulent la fonction d'une cellule
CN112088903A (zh) * 2020-09-28 2020-12-18 武汉愔紫生物科技有限公司 一种大分子蛋白在抗菌抗病毒消毒剂中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2505845A1 (fr) * 1981-05-13 1982-11-19 Choay Sa Procede de dosage de la 2',5'-oligo-adenylate-synthetase, methodes de detection d'une infection virale ou microbienne, de dosage de la concentration de l'interferon circulant ou present dans des tissus, apres administration de l'interferon, ou apres administration d'inducteurs de l'interferon et ensemble pret a l'emploi, ou kit, pour la mise en oeuvre desdits procedes de dosage et methodes de detection et de dosage
EP0113162B1 (fr) * 1982-09-16 1989-07-19 Hem Research, Inc. Effet antinéoplastiques des acides ds-ribonucléiques sur les cellules des tumeurs
CA1326450C (fr) * 1985-08-26 1994-01-25 William A. Carter Modulation des manifestations associees au virus du sida au moyen d'arn a double brin

Also Published As

Publication number Publication date
FI880960A7 (fi) 1989-06-24
DK112988A (da) 1989-06-24
OA08815A (en) 1989-03-31
HUT47745A (en) 1989-03-28
AU1618792A (en) 1992-09-10
KR890010562A (ko) 1989-08-09
NO880935L (no) 1989-06-26
PT86880A (pt) 1988-04-01
CN1043569A (zh) 1990-07-04
RU1836101C (ru) 1993-08-23
FI880960A0 (fi) 1988-03-02
AU1256488A (en) 1989-06-29
AU660973B2 (en) 1995-07-13
SU1687035A3 (ru) 1991-10-23
HU205460B (en) 1992-04-28
JP2690493B2 (ja) 1997-12-10
DK112988D0 (da) 1988-03-02
EP0325018A3 (fr) 1990-01-17
FI880960L (fi) 1989-06-24
CA1337277C (fr) 1995-10-10
NO880935D0 (no) 1988-03-02
ZA881470B (en) 1988-11-18
IL85577A0 (en) 1988-08-31
JPH01171500A (ja) 1989-07-06
EP0325018A2 (fr) 1989-07-26
PT86880B (pt) 1993-01-29

Similar Documents

Publication Publication Date Title
GB8925876D0 (en) Marker
JPS6429365A (en) Dopamine-beta-hydroxylase inhibitor
PH25365A (en) Rhase l inhibitor as a marker for virus infections
EP0420804A3 (en) Anthelmintic compounds
EP0420805A3 (en) Anthelmintic compounds
GB8824636D0 (en) Tie marker
GB8902409D0 (en) Aliphatic compounds
GB9016290D0 (en) Improved magazine for clay targets
GB2217643B (en) Line marker
IE880586L (en) RNase L INHIBITOR AS MARKER FOR AIDS
GB8917416D0 (en) Masonry marker
CA60475S (en) Marker
AU100347S (en) Direction marker
GB8717844D0 (en) Markers
GB8726071D0 (en) Marker arrangement
CS862387A1 (en) Smesny inhibitor koroze oceli
CS25787A1 (en) Inhibitor koroze
AU101207S (en) A marker
IL83693A0 (en) Assay for virus infections
ZA886709B (en) Marker devices
GB8909878D0 (en) Inhibitor
AU104259S (en) Marker case
GB9002883D0 (en) Euro marker
GB8726892D0 (en) Antipilferage tag/marker
AU7420287A (en) Non-antibiotic marker system